Suppressive effect of oral administration of branched-chain amino acid granules on oxidative stress and inflammation in HCV-positive patients with liver cirrhosis

Hepatology Research

Volumn 38, Issue 7, 2008, Pages 683-688

  Ohno, Tomoyoshi ^a   Tanaka, Yasuhito ^b   Sugauchi, Fuminaka ^b   Orito, Etsuro ^b   Hasegawa, Izumi ^a   Nukaya, Haruhiko ^a   Kato, Atsunaga ^a   Matunaga, Seijiro ^a   Endo, Masayuki ^a   Tanaka, Yoshito ^a   Sakakibara, Kenji ^a   Mizokami, Masashi ^b  

^a CHUKYO HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Branched chain amino acid; HepatitisC virus; Liver cirrhosis; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; 8 ISOPROSTANE; BRANCHED CHAIN AMINO ACID; C REACTIVE PROTEIN; FERRITIN; LIVACT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON METABOLISM; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; URINE LEVEL;

EID: 44649113152     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00319.x     Document Type: Article

References (20)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 3: 507-20.
2. Ikeda K, Saitou S, Suzuki Y et al. Disease progression and hepatocellular carcinogenesis in patients with chronic hepatitis: A prospective observation of 2215 patients. J Hepatol 1998; 28: 930-8.
3. Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-7.
4. Moriya K, Nakagawa K, Santa T et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001; 61: 4365-70.
5. Korenaga M, Wang T, Li Y et al. Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 2005; 280: 37481-8.
6. Cerutti PA. Oxy-radicals and cancer. Lancet 1994; 344: 862-3.
7. Sato S, Watanabe A, Muto Y et al. Clinical comparison of branched-chain amino acid (1-Leucine, 1-Isoleucine, 1-Valine) granules and oral nutrition for hepatic insufficiency in patients with decompensated liver cirrhosis (LIV-EN study). Hepatol Res 2005; 31: 232-40.
8. Muto Y, Sato S, Watanabe A et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Heptol Res 2006; 35: 204-214.
9. Nakano M, Kawanishi Y, Kamohara S et al. Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: A study on 2507 healthy people. Free Radic Biol Methods 2003; 35: 826-32.
10. Farinati F, Cardin R, De Maria N et al. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. J Hepatol 1995; 22: 449-56.
11. Fan ST, Lo CM, Lai EC, Chu KM, Liu CL, Wong J. Perioperative nutritional support inpatients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med 1994; 331: 1547-52.
12. Saito Y, Saito H, Nakamura M et al. Effect of the major ratio of branched-chain to aromatic acids on growth and albumin m RNA expression of human liver cancer cell lines in a serum-free medium. Nutr Cancer 2001; 39: 126-31.
13. De Maria N, Colantoni A, Fagiuoli S et al. Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radic Biol Med 1996; 21: 291-5.
14. Cardin R, Saccoccio G, Masutti F, Bellentani S, Farinati F, Tiribelli C. DNA oxidative damage in leukocytes with the severity of HCV-related liver disease: Validation in an open population study. J Heptol 2001; 35: 587-92.
15. Barbaro G, Di Lorenzo G, Asti A et al. Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: Ultrastructural and biochemical findings. Am J Gastroenterol 1999; 94: 2198-205.
16. Kato T, Miyamoto M, Date T et al. Repeated hepatocyte injury promotes hepatic tumorigenesis in hepatitis C virus transgenic mice. Cancer Sci 2003; 64: 679-85.
17. Houglum K, Venkataramani A, Lyche K, Chojkier M. A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C. Gastroenterology 1997; 113: 1069-73.
18. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histological follow-up of chronic post-transfusion hepatitis. Hepatology 1991; 14: 969-74.
19. Ryder SD, Koskinas J, Rizzi PM et al. Hepatocellular carcinoma complicating autoimmune hepatitis: Role of hepatitis C virus. Hepatology 1995; 22: 718-22.
20. Furutani T, Hino K, Okuda M et al. Hepatic iron overload induces hepatocellular carcinoma transgenic mice expressing the hepatitis C virus polyprotein. Gastroenterology 2006; 130: 2087-98.